Key result
Silent brain infarction was detected in 46% of patients with severe aortic stenosis, with higher CHA2DS2-VASc scores (≥4) and lower eGFR (<60) independently associated with greater risk (p<0.05).
Why the study?
Aortic stenosis is associated with increased risk of future symptomatic stroke, but little is known regarding the prevalence and risk factors for silent brain infarction in these patients.
Cross-Sectional (n=83)
p-value: p=< 0.05
Silent brain infarction is highly prevalent (46%) in patients with severe aortic stenosis, and its risk can be stratified using the CHA2DS2-VASc score and eGFR.
Introduction: Silent brain infarction (SBI) is an independent risk factor for subsequent symptomatic stroke in the general population. Although aortic stenosis (AS) is also known to be associated with an increased risk of future symptomatic stroke, little is known regarding the prevalence and risk factors for SBI in patients with AS. Methods: The study population comprised 83 patients with severe AS with no history of stroke or transient ischemic attack and paralysis or sensory impairment (mean age 75 ± 7 years). All patients underwent brain magnetic resonance imaging to screen for SBI and multidetector-row computed tomography to quantify the aortic valve calcification (AVC) volume. Comprehensive transthoracic and transesophageal echocardiography were performed to evaluate left atrial (LA) abnormalities, such as LA enlargement, spontaneous echo contrast, or abnormal LA appendage emptying velocity (<20 cm/s), and complex plaques in the aortic arch. Results: SBI was detected in 38 patients (46%). Multiple logistic regression analysis indicated that CHA₂DS₂-VASc score and estimated glomerular filtration rate (eGFR) were independently associated with SBI (p < 0.05), whereas LA abnormalities and AVC volume were not. When patients were divided into 4 groups according to CHA₂DS₂-VASc score and eGFR, the group with a higher CHA₂DS₂-VASc score (≥4) and a lower eGFR (<60 mL/min/1.73 m²) had a greater risk of SBI than the other groups (p < 0.05). Conclusion: These findings indicate that AS is associated with a high prevalence of SBI, and that the CHA₂DS₂-VASc score and eGFR are useful for risk stratification.
No takes yet. Share an insight, caveat, or question.
Ito et al. (2020) conducted a cross-sectional in Severe aortic stenosis (n=83). Higher CHA2DS2-VASc score (≥4) and lower eGFR (<60 mL/min/1.73 m2) vs. Lower CHA2DS2-VASc score and higher eGFR was evaluated on Silent brain infarction (SBI) (p=< 0.05). Silent brain infarction was detected in 46% of patients with severe aortic stenosis, with higher CHA2DS2-VASc scores (≥4) and lower eGFR (<60) independently associated with greater risk (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: